These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 16210859
21. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation. Kurowski M, Kuna P, Górski P. Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509 [Abstract] [Full Text] [Related]
22. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial. Meltzer EO, Jalowayski AA, Vogt K, Iezzoni D, Harris AG. Ann Allergy Asthma Immunol; 2006 Feb; 96(2):363-8. PubMed ID: 16498861 [Abstract] [Full Text] [Related]
23. The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis. Sullivan PW, Navaratnam P, Lorber R, Shekar T. Curr Med Res Opin; 2010 Jun; 26(6):1389-97. PubMed ID: 20384438 [Abstract] [Full Text] [Related]
24. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis. Raphael GD, Angello JT, Wu MM, Druce HM. Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933 [Abstract] [Full Text] [Related]
25. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. Day JH, Briscoe M, Widlitz MD. J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501 [Abstract] [Full Text] [Related]
26. The effects of inhaled budesonide on circulating eosinophil progenitors and their expression of cytokines after allergen challenge in subjects with atopic asthma. Gauvreau GM, Wood LJ, Sehmi R, Watson RM, Dorman SC, Schleimer RP, Denburg JA, O'Byrne PM. Am J Respir Crit Care Med; 2000 Dec; 162(6):2139-44. PubMed ID: 11112128 [Abstract] [Full Text] [Related]
27. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis. Pleskow W, Grubbe R, Weiss S, Lutsky B. Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245 [Abstract] [Full Text] [Related]
28. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM. Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468 [Abstract] [Full Text] [Related]
29. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis. Ciebiada M, Górska-Ciebiada M, DuBuske LM, Górski P. Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277 [Abstract] [Full Text] [Related]
30. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis. Ciebiada M, Gorska-Ciebiada M, Barylski M, Kmiecik T, Gorski P. Am J Rhinol Allergy; 2011 Nov; 25(1):e1-6. PubMed ID: 21711959 [Abstract] [Full Text] [Related]
32. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Berger WE, Schenkel EJ, Mansfield LE, Desloratadine Study Group. Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207 [Abstract] [Full Text] [Related]
33. [The effect of desloratadine on the TXB2 and leukotrienes levels in the nasal lavage fluid of allergic rhinitis animal model]. Zhao Y, Van Hasselt CA, Woo K, Wong Y, Leung P. Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(8):365-7. PubMed ID: 16075993 [Abstract] [Full Text] [Related]
34. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. Ciebiada M, Ciebiada MG, Kmiecik T, DuBuske LM, Gorski P. J Investig Allergol Clin Immunol; 2008 Apr; 18(5):343-9. PubMed ID: 18973097 [Abstract] [Full Text] [Related]
35. [Oral second generation antihistamines in allergic rhinitis]. Riechelmann H. Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976 [Abstract] [Full Text] [Related]
36. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review. Bachert C, van Cauwenberge P. Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184 [Abstract] [Full Text] [Related]
37. The effect of 4 weeks treatment with desloratadine (5mg daily) on levels of interleukin (IL)-4, IL-10, IL-18 and TGF beta in patients suffering from seasonal allergic rhinitis. Tworek D, Bocheńska-Marciniak M, Kupczyk M, Górski P, Kuna P. Pulm Pharmacol Ther; 2007 Sep; 20(3):244-9. PubMed ID: 16530440 [Abstract] [Full Text] [Related]
39. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. Ratner PH, van Bavel JH, Martin BG, Hampel FC, Howland WC, Rogenes PR, Westlund RE, Bowers BW, Cook CK. J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799 [Abstract] [Full Text] [Related]
40. Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis. Ratner P, Falqués M, Chuecos F, Esbrí R, Gispert J, Peris F, Luria X, Rosales MJ. Int Arch Allergy Immunol; 2005 Dec; 138(4):312-8. PubMed ID: 16224195 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]